Major shareholder sold
Casdin Partners Master Fund · Traded May 19 – May 21, 2026 · largest single filing ~$15.4M
Show all 3 filings
May 21, 2026~$15.4M · 650K sh @ $23.70
DetailsOfficial record
Loading…
BLFS · NASDAQ · Health Care Supplies
Health Care Supplies company based in Bothell, Washington.
In the last 90 days, no insider of BioLife Solutions, Inc. reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$38.61
Last 12 months
Not enough history
Market value
$1.89B
Revenue
$28.5M
+21.5% vs the same quarter a year earlier
Free cash flow, last 12 months
$5.3M
This quarter $5.3M, a year earlier $5.63M
Net cash
$24M
Debt $0, cash $24M, at Jun 30, 2026
Net income, last 12 months
$58M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 6, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$96.2M
+28.9% vs the year before
Net income, fiscal 2025
−$4.59M
A loss for the year
Shares outstanding
48.9M
As of Jul 30, 2026
Casdin Partners Master Fund · Traded May 19 – May 21, 2026 · largest single filing ~$15.4M
May 21, 2026~$15.4M · 650K sh @ $23.70
DetailsOfficial recordMay 19, 2026~$6.79M · 300K sh @ $22.65
May 20, 2026~$5.92M · 250K sh @ $23.70
DetailsOfficial recordOfficer sold ~$49K of BioLife Solutions, Inc.
Scheduled in advanceStock since the trade +91.9% · S&P 500 +13.7% · to Oct 5
BioLife Solutions's Chief Quality and Operations sold $1.95M of BioLife Solutions shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $26.52 on Oct 6, 2025 to $38.61 on Oct 5, 2026 (+45.6%). Disclosed activity in the last 12 months: 0 insider purchases, 48 insider sales (32 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
Notice of delisting or failure to meet listing rules
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.